Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=elnLatest Financial News for ELAN CP PLC ADRen-usTue, 5 Jan 2010 22:33:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100105/20100105007072.html?.v=1DUBLIN----Elan Corporation, plc today announced that it will present at the 28th Annual J.P. Morgan Healthcare Conference, on Wednesday, January 13, 2010, at 9:00 a.m. Pacific Time, noon Eastern Time and 5:00 p.m.yahoo_finance/3339289645Tue, 5 Jan 2010 22:33:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12gjp3ld8/*http%3A//www.fool.com/investing/general/2010/01/05/best-stocks-to-buy-now.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1854225837Tue, 5 Jan 2010 19:39:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12p38979a/*http%3A//www.fool.com/investing/general/2010/01/05/biogen-idecs-ceo-calls-it-quits.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3917870668Tue, 5 Jan 2010 19:25:37 Etc/GMThttp://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=153ivva4g/*http%3A//www.minyanville.com/articles/biogen-james-mullen-president-ceo-retire-carl-icahn-investor-buy-board-members-Tysabri-minyanville/index/a/26219/from/yahooCEO James Mullen will step down after a tumultuous tenure.yahoo_finance/928243280Tue, 5 Jan 2010 18:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/forbes/rss/SIG=13elcmk1f/*http%3A//www.forbes.com/2010/01/05/terrorism-breast-implants-airports-opinions-contributors-elan-singer.html?partner=yahootixyahoo_finance/1850562795Tue, 5 Jan 2010 17:27:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13erap18q/*http%3A//www.fool.com/investing/high-growth/2009/12/29/some-brand-name-patents-going-going-gone-in-2010.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/136459014Tue, 29 Dec 2009 21:20:48 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12i3lk74q/*http%3A//www.fool.com/investing/value/2009/12/24/this-top-stock-is-a-winner.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/4170129196Thu, 24 Dec 2009 14:43:06 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12ur4i8sa/*http%3A//seekingalpha.com/article/179030-this-week-s-failed-trials-missed-targets-in-biotech?source=yahooyahoo_finance/381374615Sun, 20 Dec 2009 12:08:03 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12t1475gd/*http%3A//www.fool.com/investing/high-growth/2009/12/18/3-reasons-to-buy-dendreon-today.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/680562435Fri, 18 Dec 2009 19:34:01 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091217/28450.html?.v=1Johnson & Johnson has been in an acquisitive mode during the year, the Acclarent buyout being the latest.yahoo_finance/3986210123Thu, 17 Dec 2009 21:30:58 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13fi6e99h/*http%3A//seekingalpha.com/article/178468-report-from-europe-stocks-recovering-after-data-points-to-dovish-fed?source=yahooyahoo_finance/3022656032Wed, 16 Dec 2009 15:48:29 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12ub6rpb2/*http%3A//www.thestreet.com/_yahoo/story/10645407/1/five-biotech-events-to-watch-in-2010.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3781450522Wed, 16 Dec 2009 15:23:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ts/091216/10645407.html?.v=1yahoo_finance/3756351739Wed, 16 Dec 2009 15:23:40 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12jtl30r6/*http%3A//www.marketwatch.com/news/story/elan-gilead-sciences-lead-drug/story.aspx?guid=%7B5594CA7A%2DCA38%2D4C2A%2DA635%2D145F2DC055FB%7D&siteid=yhoofShares of Elan lose ground over negative reports about its drug candidate for treating Alzheimer's disease.yahoo_finance/4003480282Tue, 15 Dec 2009 20:34:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12lk59obq/*http%3A//www.fool.com/investing/high-growth/2009/12/15/forget-the-higher-doses.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1804156387Tue, 15 Dec 2009 20:16:14 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12sfoeiqj/*http%3A//www.fool.com/investing/value/2009/12/15/is-this-company-really-earning-money.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3863879705Tue, 15 Dec 2009 19:10:03 Etc/GMThttp://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=136857p9q/*http%3A//www.foxbusiness.com/story/markets/industries/health-care/elan-stop-alzheimers-trial-deaths/yahoo_finance/58944629Tue, 15 Dec 2009 16:02:21 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12o07vp85/*http%3A//www.marketwatch.com/news/story/elan-partially-shuts-down-alzheimer/story.aspx?guid=%7BCC5B9833%2DF261%2D43EF%2DAAD1%2D65A5928D080D%7D&siteid=yhoofyahoo_finance/1619365773Tue, 15 Dec 2009 15:14:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12o831h8i/*http%3A//www.marketwatch.com/news/story/elan-partially-shuts-down-alzhiemer/story.aspx?guid=%7BCC5B9833%2DF261%2D43EF%2DAAD1%2D65A5928D080D%7D&siteid=yhoofElan Corp. said early Tuesday said that it was discontinuing testing of a higher dose of its Alzheimer's disease drug candidate after nine deaths were reported in a Phase II clinical study.yahoo_finance/152935562Tue, 15 Dec 2009 15:09:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh85768_2009-12-15_14-43-48_n15222584_newsml&rpc=44&type=marketsNewsyahoo_finance/1199039269Tue, 15 Dec 2009 14:43:48 Etc/GMT